Nagel TC, Freinkel N, Bell RH, et al. Gynecomastia, prolactin, and other peptide hormones in patients undergoing chronic hemodialysis. J Clin Endocrinol Metab 1973;36:428–432.
312.
Olgaard K, Hagen C, McNeilly AS. Pituitary hormones in women with chronic renal failure: the effect of chronic intermittent haemoand peritoneal dialysis. Acta Endocrinol (Copenh) 1975;80:237– 246.
313.
Thorner MO, Edwards CRW, Hanker JP. Prolactin and gonadotropin interaction in the male. In: Troen P, Nankin H, eds. The testis in normal and infertile men. New York: Raven Press, 1977:351–366.
314.
Lloyd RV. Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland. An immunohistochemical study. Am J Pathol 1983;113:198–206.
315.
Scheithauer BW, Sano T, Kovacs KT, et al. The pituitary gland in pregnancy: a clinicopathologic and immunohistochemical study of 69 cases. Mayo Clin Proc 1990;65:461–474.
316.
Weil C. The safety of bromocriptine in hyperprolactinaemic female infertility: a literature review. Curr Med Res Opin 1986;10:172–195.
317.
Shy KK, McTiernan AM, Daling JR, et al. Oral contraceptive use and the occurrence of pituitary prolactinoma. JAMA 1983;249:2204– 2207.
318.
Corenblum B, Taylor PJ. Idiopathic hyperprolactinemia may include a distinct entity with a natural history different from that of prolactin adenomas. Fertil Steril 1988;49:544–546.
319.
Corenblum B, Donovan L. The safety of physiological estrogen plus progestin replacement therapy and with oral contraceptive therapy in women with pathological hyperprolactinemia. Fertil Steril 1993;59:671–673.
320.
Scheithauer BW, Kovacs KT, Randall RV, et al. Effects of estrogen on the human pituitary: a clinicopathologic study. Mayo Clin Proc 1989;64:1077–1084.
321.
Raymond JP, Goldstein E, Konopka P, et al. Follow-up of children born of bromocriptine-treated mothers. Horm Res 1985;22:239–246.
322.
Ruiz-Velasco V, Tolis G. Pregnancy in hyperprolactinemic women. Fertil Steril 1984;41:793–805.
323.
Turkalj I, Braun P, Krupp P. Surveillance of bromocriptine in pregnancy. JAMA 1982;247:1589–1591.
324.
Katz M, Kroll D, Pak I, et al. Puerperal hypertension, stroke, and seizures after suppression of lactation with bromocriptine. Obstet Gynecol 1985;66:822–824.
325.